Literature DB >> 3973515

Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig.

J L Witztum, S G Young, R L Elam, T E Carew, M Fisher.   

Abstract

In previous animal studies, bile acid sequestrant resins have been shown to increase the fractional catabolic rate (FCR) of a low density lipoprotein (LDL) tracer isolated from a normal donor animal and to increase hepatic LDL-receptor activity. In addition, in man, these resins are known to alter LDL composition such that low density lipoproteins are smaller, more dense, and have a decreased cholesterol:protein ratio. To determine whether metabolic consequences resulted from these changes in LDL composition, we fed cholestyramine chow (2% resin by weight) to guinea pigs, which lowered LDL cholesterol levels by 55%. LDL was isolated from control donors (C-LDL) and from cholestyramine-treated donors (CH-LDL). Compared to the C-LDL, the CH-LDL were smaller in size, depleted of cholesteryl ester and phospholipid, and had a marked decrease in their cholesterol:protein ratio. To determine whether the clearance of the altered CH-LDL was different from that of C-LDL, we labeled the two LDL preparations with 125I or 131I and simultaneously injected them into control and cholestyramine-treated guinea pigs. In 27/29 animals studied, the FCR of the CH-LDL was slower than that of C-LDL, demonstrating that the compositional changes alter the metabolism of CH-LDL. When C-LDL was used as the sole tracer in both control and treated animals, cholestyramine treatment increased the FCR by 41%; when CH-LDL was used as sole tracer, the increase in FCR on treatment was only 26%. This suggested that C-LDL was cleared more rapidly by the LDL-receptor pathway than was CH-LDL. Further support for this idea came from observations that C-LDL was degraded more readily by cultured fibroblasts and that nonenzymatic glucosylation abolished the difference in FCR between C-LDL and CH-LDL. These studies show that the effects of bile sequestration are complex and that the compositional changes produced have profound metabolic consequences. The implications of these observations for interpretation of LDL turnover studies are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973515

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.

Authors:  E Gherardi; D E Bowyer; C Fitzsimmons; T Le Cras; A Hutchings; G Butcher
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

2.  Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

Authors:  S G Young; S J Bertics; L K Curtiss; D C Casal; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Influence of age on the metabolism of plasma low density lipoproteins in healthy males.

Authors:  S Ericsson; M Eriksson; S Vitols; K Einarsson; L Berglund; B Angelin
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.

Authors:  L Berglund; J L Witztum; N F Galeano; A S Khouw; H N Ginsberg; R Ramakrishnan
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

Review 5.  Lowering cholesterol, 1988. Rationale, mechanisms, and means.

Authors:  R J Havel
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.

Authors:  J Thiery; C Creutzfeldt; W Creutzfeldt; A K Walli; D Seidel
Journal:  Klin Wochenschr       Date:  1990-08-17

7.  Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

8.  Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin.

Authors:  S M Bartlett; G F Gibbons
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

9.  Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody.

Authors:  C Fitzsimmons; R Bush; D Hele; C Godliman; E Gherardi; D E Bowyer
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

10.  Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.

Authors:  S Vitols; B Angelin; S Ericsson; G Gahrton; G Juliusson; M Masquelier; C Paul; C Peterson; M Rudling; K Söderberg-Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.